CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Part 1 — Disease Prevention & Health Promotion (5 items)
Item 1
Reference: Part 1 — Disease Prevention & Health Promotion —
Cancer Screening (Breast and Colorectal)
Question stem:
A 58-year-old woman with no significant medical history asks
about cancer screening. She has no family history of colorectal
or breast cancer and had a normal mammogram 18 months
ago. Which screening recommendation most appropriately
aligns with evidence-based preventive guidance?
,Options:
A. Begin annual colonoscopy now and repeat every 2 years.
B. Continue mammography every 1–2 years and initiate
colorectal cancer screening with colonoscopy now.
C. Defer mammography until 5 years from now and perform
annual fecal occult blood testing.
D. Start PSA testing and colonoscopy every 10 years.
Correct answer: B
Rationales:
• Correct (B): For average-risk women aged 50–75,
colorectal screening should be initiated (colonoscopy or
other accepted modalities), and mammography remains
recommended at routine intervals (generally every 1–2
years depending on guideline/age). This balances benefits
of early cancer detection and evidence-based intervals.
USPSTF+1
• A (incorrect): Colonoscopy is not performed every 2 years
in average-risk individuals; typical interval is 10 years after
a normal exam.
• C (incorrect): Deferring mammography for five years is not
consistent with routine screening in this age group; annual
fecal occult testing alone is less preferred than structural
exams like colonoscopy when available.
, • D (incorrect): PSA testing is not indicated in all women
(nonsensical here) and colonoscopy every 10 years is
correct interval but PSA is inappropriate.
Teaching point:
Start colorectal screening at age 50–75 and maintain routine
mammography per age-based intervals.
Citation:
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Part 1.
Item 2
Reference: Part 1 — Disease Prevention & Health Promotion —
Immunizations (Adults)
Question stem:
A 67-year-old man with well-controlled type 2 diabetes asks
which vaccines he should receive during his annual visit. He had
influenza vaccine last year and received pneumococcal
vaccination at age 66. Which vaccine is most important to
ensure now?
Options:
A. No additional vaccines needed this year.
B. Herpes zoster vaccine (recommended for adults ≥50).
C. Repeat pneumococcal vaccine immediately.
D. HPV vaccine.
, Correct answer: B
Rationales:
• Correct (B): Herpes zoster vaccination is recommended for
older adults (commonly starting at age ≥50) to reduce
herpes zoster incidence and complications; diabetics
benefit from immunization. CDC adult immunization
guidance supports zoster vaccination for older adults. CDC
• A (incorrect): Annual influenza is indicated each season;
additional vaccines such as zoster should be assessed.
• C (incorrect): Routine repeat pneumococcal vaccination
timing depends on vaccine type and prior dosing—
immediate repeat without indication is inappropriate.
• D (incorrect): HPV vaccine is generally recommended for
younger adults (through age 26 routinely; selective/shared
decision-making up to 45).
Teaching point:
Recommend zoster vaccine for adults ≥50 to prevent shingles
and complications.
Citation:
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Part 1.
Item 3
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Part 1 — Disease Prevention & Health Promotion (5 items)
Item 1
Reference: Part 1 — Disease Prevention & Health Promotion —
Cancer Screening (Breast and Colorectal)
Question stem:
A 58-year-old woman with no significant medical history asks
about cancer screening. She has no family history of colorectal
or breast cancer and had a normal mammogram 18 months
ago. Which screening recommendation most appropriately
aligns with evidence-based preventive guidance?
,Options:
A. Begin annual colonoscopy now and repeat every 2 years.
B. Continue mammography every 1–2 years and initiate
colorectal cancer screening with colonoscopy now.
C. Defer mammography until 5 years from now and perform
annual fecal occult blood testing.
D. Start PSA testing and colonoscopy every 10 years.
Correct answer: B
Rationales:
• Correct (B): For average-risk women aged 50–75,
colorectal screening should be initiated (colonoscopy or
other accepted modalities), and mammography remains
recommended at routine intervals (generally every 1–2
years depending on guideline/age). This balances benefits
of early cancer detection and evidence-based intervals.
USPSTF+1
• A (incorrect): Colonoscopy is not performed every 2 years
in average-risk individuals; typical interval is 10 years after
a normal exam.
• C (incorrect): Deferring mammography for five years is not
consistent with routine screening in this age group; annual
fecal occult testing alone is less preferred than structural
exams like colonoscopy when available.
, • D (incorrect): PSA testing is not indicated in all women
(nonsensical here) and colonoscopy every 10 years is
correct interval but PSA is inappropriate.
Teaching point:
Start colorectal screening at age 50–75 and maintain routine
mammography per age-based intervals.
Citation:
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Part 1.
Item 2
Reference: Part 1 — Disease Prevention & Health Promotion —
Immunizations (Adults)
Question stem:
A 67-year-old man with well-controlled type 2 diabetes asks
which vaccines he should receive during his annual visit. He had
influenza vaccine last year and received pneumococcal
vaccination at age 66. Which vaccine is most important to
ensure now?
Options:
A. No additional vaccines needed this year.
B. Herpes zoster vaccine (recommended for adults ≥50).
C. Repeat pneumococcal vaccine immediately.
D. HPV vaccine.
, Correct answer: B
Rationales:
• Correct (B): Herpes zoster vaccination is recommended for
older adults (commonly starting at age ≥50) to reduce
herpes zoster incidence and complications; diabetics
benefit from immunization. CDC adult immunization
guidance supports zoster vaccination for older adults. CDC
• A (incorrect): Annual influenza is indicated each season;
additional vaccines such as zoster should be assessed.
• C (incorrect): Routine repeat pneumococcal vaccination
timing depends on vaccine type and prior dosing—
immediate repeat without indication is inappropriate.
• D (incorrect): HPV vaccine is generally recommended for
younger adults (through age 26 routinely; selective/shared
decision-making up to 45).
Teaching point:
Recommend zoster vaccine for adults ≥50 to prevent shingles
and complications.
Citation:
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Part 1.
Item 3
